1. Home
  2. TIGR vs WVE Comparison

TIGR vs WVE Comparison

Compare TIGR & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIGR
  • WVE
  • Stock Information
  • Founded
  • TIGR 2014
  • WVE 2012
  • Country
  • TIGR Singapore
  • WVE Singapore
  • Employees
  • TIGR N/A
  • WVE N/A
  • Industry
  • TIGR Investment Bankers/Brokers/Service
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • TIGR Finance
  • WVE Health Care
  • Exchange
  • TIGR Nasdaq
  • WVE Nasdaq
  • Market Cap
  • TIGR 1.2B
  • WVE 939.3M
  • IPO Year
  • TIGR 2019
  • WVE 2015
  • Fundamental
  • Price
  • TIGR $8.88
  • WVE $6.30
  • Analyst Decision
  • TIGR Buy
  • WVE Strong Buy
  • Analyst Count
  • TIGR 2
  • WVE 11
  • Target Price
  • TIGR $8.54
  • WVE $20.91
  • AVG Volume (30 Days)
  • TIGR 3.9M
  • WVE 1.8M
  • Earning Date
  • TIGR 06-04-2025
  • WVE 05-08-2025
  • Dividend Yield
  • TIGR N/A
  • WVE N/A
  • EPS Growth
  • TIGR 77.02
  • WVE N/A
  • EPS
  • TIGR 0.37
  • WVE N/A
  • Revenue
  • TIGR $330,737,913.00
  • WVE $104,939,000.00
  • Revenue This Year
  • TIGR $53.12
  • WVE N/A
  • Revenue Next Year
  • TIGR $16.72
  • WVE N/A
  • P/E Ratio
  • TIGR $26.62
  • WVE N/A
  • Revenue Growth
  • TIGR 46.64
  • WVE N/A
  • 52 Week Low
  • TIGR $3.36
  • WVE $4.25
  • 52 Week High
  • TIGR $14.48
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • TIGR 51.73
  • WVE 39.82
  • Support Level
  • TIGR $9.65
  • WVE $5.62
  • Resistance Level
  • TIGR $10.17
  • WVE $7.07
  • Average True Range (ATR)
  • TIGR 0.48
  • WVE 0.60
  • MACD
  • TIGR 0.08
  • WVE -0.00
  • Stochastic Oscillator
  • TIGR 35.92
  • WVE 24.55

About TIGR UP Fintech Holding Ltd representing fifteen

UP Fintech Holding Ltd is an online brokerage firm focusing on Chinese investors. Its trading platform enables investors to trade in equities and other financial instruments on multiple exchanges of stocks and other derivatives. The company offers its customers brokerage and value-added services, including trade order placement and execution, margin financing, account management, investor education, community discussion, and customer support.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: